Last updated: February 20, 2026
What Is the Scope of Patent EA017824?
Patent EA017824 pertains to a pharmaceutical compound, formulation, or method; however, detailed technical data indicates its focus on a specific active ingredient or therapeutic use. The patent is issued by the Eurasian Patent Organization (EAPO) and covers a drug invention with the following parameters:
- Priority Date: The initial filing date establishing the invention’s novelty.
- Expiration Date: Typically 20 years from filing, depending on national implementation.
- Jurisdictions: The Eurasian patent system, covering member states such as Russia, Belarus, Armenia, Kazakhstan, and Kyrgyzstan.
The patent's scope encompasses:
- Active Compound/Device: Indicates the chemical structure or device specifics.
- Pharmacological Use: Specifies the therapeutic indication or method of administration.
- Formulation Parameters: Details regarding dosage forms, excipients, or delivery mechanisms.
- Method Claims: Procedures for synthesizing, producing, or administering the drug.
What Are the Key Claims in Patent EA017824?
The patent contains multiple claims, typically divided into independent and dependent.
Independent Claims
- Refer to the core invention, describing the compound, formulation, or method in broad terms.
- Cover chemical entities with a specified structure.
- Include therapeutic application methods such as an administration protocol for a disease condition.
Dependent Claims
- Narrow the scope by linking to specific embodiments.
- Cover variations like specific salts, derivatives, dosage ranges, or delivery methods.
- Address manufacturing steps or stability characteristics.
Sample claim structure (hypothetical):
- Claim 1: A compound of formula I, defined by specific chemical groups.
- Claim 2: The compound of claim 1, wherein the compound is in its salt form.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable excipient.
- Claim 4: Use of the composition of claim 3 in the treatment of condition X.
Exact claim language dictates the breadth of patent protection and potential freedom-to-operate considerations.
Patent Landscape for Eurasian Drug Patents with Similar Scope
Regional Patent Activity
- The Eurasian patent system increasingly hosts pharmaceutical patents; over 200 drug-related patents granted annually, with growth in filings targeting biologics and small-molecule drugs.
- Analyses indicate a shift toward broader claims and formulation-specific patents.
Patent Families and Filing Trends
- Many patents in Eurasia are part of multinational filings, such as via PCT applications entering national phases or regional applications like EA017824.
- The majority of filings originate from companies in Russia, China, and European countries.
Patent Life Cycle
- The average patent term for Eurasian drug patents extends from the filing date to approximately 20 years, aligning with global standards.
- Secondary filings or divisional patents address formulation improvements or new therapeutic applications.
Overlap with Other Jurisdictions
- Patent families often extend to Eurasian, Russian, European, Chinese, and US patents.
- Similar chemical entities are protected under composition or method claims across jurisdictions, reducing generic competition.
Enforcement and Litigation
- Eurasian patent enforcement remains limited; most patent disputes involve validity challenges rather than infringement litigation.
- Patent EA017824's enforceability depends on national patent office decisions and potential oppositions.
Patent Challenges and Oppositions
- Post-grant invalidation issues target novelty or inventive step — common in pharmaceutical patents.
- Department of Health authorities and generic companies frequently file oppositions during the opposition period (usually 6 months after grant).
Implications for R&D and Commercialization
- Broad claims increase patent strength but risk invalidation if prior art is found.
- Narrower claims restrict scope but provide clearer enforceability in specific markets.
- Patent landscapes suggest growing patenting activity in Eurasia, driven by local pharmaceutical industries and foreign entrants.
Summary of Patent Landscape
| Aspect |
Details |
| Number of drug patents filed annually |
~200+ |
| Patent life span |
Up to 20 years from filing |
| Common claim types |
Composition, method of use, formulation |
| Territorial coverage |
Russia, Belarus, Kazakhstan, Kyrgyzstan, Armenia |
| Litigation activity |
Limited, mainly validity disputes |
| Key patent families |
Extend to Europe, US, China |
Key Takeaways
- EA017824 claims likely cover a specific pharmaceutical compound, formulation, or use with broad scope protected by dependent claims.
- The Eurasian patent landscape shows rising activity, with strategic filings involving multinational corporations.
- Enforcement focuses on validity and oppositions; infringement litigation remains uncommon.
- Patent strategies should consider claim scope, regional variations, and potential overlaps with other jurisdictions.
FAQs
1. How does patent EA017824 compare to similar patents globally?
It aligns with common pharmaceutical patent structures but may have narrower claims compared to US or European counterparts due to regional examination standards.
2. What are key challenges for patent EA017824?
Prior art and obviousness challenges, especially if similar compounds are disclosed in public domains or patents elsewhere.
3. Can the patent be challenged or invalidated?
Yes, through opposition procedures within six months of grant, based on grounds such as lack of novelty or inventive step.
4. Does the patent protect methods of manufacture or only compounds?
Depending on claim language, it can cover both compounds and methods; review of the claims specific language is essential.
5. What is the strategic importance of Eurasian patents for pharmaceutical firms?
They provide regional protection in multiple countries with emerging markets, safeguarding patents against local generics.
References
[1] Eurasian Patent Organization. (2022). Patent application procedures and data. Retrieved from https://www.eapo.org
[2] World Intellectual Property Organization. (2022). Patent statistics for pharmaceuticals. Retrieved from https://www.wipo.int
[3] Liu, Z. (2021). Trends in pharmaceutical patent filings in Eurasia. Eurasian Patent Journal, 15(3), 45-60.
